Microelectrode Assembly with Plasmonic Nanostructures for Neurotransmitter Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional electrochemical detection methods, such as fast-scan cyclic voltammetry (FSCV), face challenges in efficiently detecting neurotransmitters at low levels in vivo due to interference compounds and limited temporal and spatial resolution, making it difficult to accurately measure basal levels and differentiate between neurotransmitters like dopamine and ascorbic acid.

Innovation Solution

A microelectrode assembly with plasmonic nanostructures formed from alloys like gold, silver, platinum, and palladium is integrated into the FSCV platform, enhancing detection efficiency by using surface-enhanced Raman spectroscopy for real-time monitoring of neurotransmitters, including catecholamine-based compounds, through improved spatial and temporal resolution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional FSCV methods are used for neurotransmitter detection, then temporal resolution can be maintained at 10 Hz, but detection sensitivity and spatial resolution are insufficient for trace amount neurotransmitters in vivo

Engineering Contradiction:
Improvedetection sensitivityVSAvoidtemporal resolution
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent employs a composite microelectrode structure combining carbon fiber base material with deposited metal nanostructures (gold, platinum, or copper). This composite approach leverages the electrochemical stability of carbon fiber while incorporating the plasmonic properties of metals to enhance Raman scattering signals, achieving femtomolar detection sensitivity without compromising temporal resolution at 10 Hz scanning rates

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent transitions from purely electrochemical detection to a hybrid approach incorporating surface-enhanced Raman scattering (SERS), an optical phenomenon. By substituting part of the detection mechanism with optical field interactions at the nanostructure surface, the system achieves enhanced sensitivity through electromagnetic field concentration while maintaining the temporal resolution benefits of fast-scan cyclic voltammetry

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If conventional FSCV with background subtraction is used, then changes in neurotransmitter levels can be detected, but basal levels cannot be determined and ascorbic acid interference cannot be resolved

Engineering Contradiction:
ImprovespecificityVSAvoidbasal level information
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The patent utilizes Raman spectroscopy, which detects molecular vibrations that produce characteristic spectral fingerprints for different neurotransmitters. Each neurotransmitter (dopamine, ascorbic acid, serotonin) has a unique Raman spectrum, allowing differentiation based on spectral characteristics rather than relying on background subtraction methods that lose basal level information and cannot distinguish between compounds with similar electrochemical behaviors

Inventive Principle:
Principle #32Color changes

3Measurement precision

If microdialysis or enzyme-linked immunosorbent assay methods are used, then neurotransmitter levels can be measured, but temporal resolution is low (1 minute or more) and real-time monitoring is not achievable

Engineering Contradiction:
Improvemeasurement accuracyVSAvoidtemporal resolution
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent employs fast-scan cyclic voltammetry with periodic triangular voltage waveforms applied at 10 Hz scanning rates. This periodic electrochemical stimulation, combined with the surface-enhanced Raman scattering effect, enables rapid sequential measurements that capture real-time neurotransmitter dynamics with millisecond temporal resolution, overcoming the minute-scale limitations of microdialysis and ELISA methods

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS11647927B2Microelectrode assembly for monitoring of in vivo neurotransmitters
Publication Date: 2023.05.16 SAMSUNG LIFE PUBLIC WELFARE FOUND
  • US11647927B2 patent drawing
  • US11647927B2 patent drawing
  • US11647927B2 patent drawing

AI summary

A microelectrode assembly for in vivo neurotransmitter monitoring according to one embodiment of the present disclosure includes: a microelectrode part formed of a single strand; and a polymer coating layer surrounding the microelectrode part, wherein a portion of the microelectrode part may protrude from the polymer coating layer, neurotransmitters in vivo may be sensed by the protruding portion of the microelectrode part, and plasmonic nanostructures may be formed on the surface of the microelectrode part.